Clinical trial · Observational
The CHOICE Registry
The CHOICE Registry: A Research Initiative Examining Clinical, Economic, and Humanistic Outcomes in the Management of Metastatic Colorectal Cancer
NCT03148093CI-TRIAL-00080431terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Competing clinical trials and slower than expected patient enrollment
Summary
Brief summary (as posted)
The CHOICE Registry will describe real-world treatment patterns and physician and patient (and caregiver)-reported outcomes associated with patients who have progressed beyond 2nd line metastatic colorectal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (9)
- measure
- Real-world treatment patterns as assessed by FACT/NCCN-Colorectal Symptom Index-19 (FCSI-19)
- timeFrame
- Approximately 15 months
- measure
- Real-world treatment patterns as assessed by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)
- timeFrame
- Approximately 15 months
- measure
- Real-world treatment patterns as assessed by EuroQoL EQ-5D-5L
- timeFrame
- Approximately 15 months
- measure
- Real-world treatment patterns as assessed by Medication Satisfaction Questionnaire (MSQ)
- timeFrame
- Approximately 15 months
- measure
- Real-world treatment patterns as assessed by Modified Caregiver Strain Index (MCSI)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age ≥ 18 2. Diagnosis of metastatic CRC 3. Having completed first and second lines of treatment for metastatic CRC 4. Intending (at time of enrollment) to initiate a third (or subsequent) line of treatment 5. Ability to understand and read English or Spanish 6. Willing and able to sign an Informed Consent Form (ICF), or have a Legally Authorized Representative willing and able to consent on the patient's behalf Exclusion Criteria: 1. Patient is unwilling or unable to participate in the Registry at the time of enrollment 2. The patient is currently participating in an investigational clinical trial 3. Patients not having mental capacity and or ability to participate in the Registry
References
Publications (0)
Data not yet available
No reference posted for this study.